D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 70 Citations 14,706 219 World Ranking 15847 National Ranking 8263

Overview

What is he best known for?

The fields of study he is best known for:

  • Surgery
  • Internal medicine
  • Cancer

Bryan F. Meyers mostly deals with Surgery, Internal medicine, Transplantation, Lung transplantation and Lung cancer. His Surgery research is multidisciplinary, incorporating elements of Respiratory disease, Lung and Pneumonectomy. His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology, Oncology and Cardiology.

His Transplantation research incorporates themes from Anesthesia, Hypoxemia and Membrane oxygenator. Bryan F. Meyers combines subjects such as Cystic fibrosis, Airway and Incidence with his study of Lung transplantation. The study incorporates disciplines such as Stage, Cancer and Radiology in addition to Lung cancer.

His most cited work include:

  • Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network (2762 citations)
  • Morbidity and Mortality of Major Pulmonary Resections in Patients With Early-Stage Lung Cancer: Initial Results of the Randomized, Prospective ACOSOG Z0030 Trial (495 citations)
  • Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. (280 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Surgery, Internal medicine, Lung cancer, Lung and Lung transplantation. His Surgery research is multidisciplinary, relying on both Respiratory disease, Cancer and Pneumonectomy. His Pneumonectomy research is multidisciplinary, incorporating perspectives in Thoracotomy and Propensity score matching.

His biological study deals with issues like Oncology, which deal with fields such as Chemotherapy and Neoadjuvant therapy. His research investigates the connection between Lung cancer and topics such as Radiology that intersect with issues in Malignancy. His Lung transplantation research includes elements of Cardiology and Intensive care medicine.

He most often published in these fields:

  • Surgery (55.88%)
  • Internal medicine (26.47%)
  • Lung cancer (22.06%)

What were the highlights of his more recent work (between 2016-2021)?

  • Internal medicine (26.47%)
  • Surgery (55.88%)
  • Cancer (12.87%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Internal medicine, Surgery, Cancer, Esophageal cancer and Esophagectomy. His Internal medicine research focuses on subjects like Oncology, which are linked to Chemotherapy and Esophagus. The concepts of his Surgery study are interwoven with issues in Odds ratio, Lung cancer and Stage I Non-Small Cell Lung Cancer.

The Lung cancer study combines topics in areas such as Carcinoma and Radiology, Computed tomography. His Esophageal cancer study integrates concerns from other disciplines, such as Neoadjuvant therapy, Quality of life, Adjuvant therapy and Adenocarcinoma. His study in Retrospective cohort study is interdisciplinary in nature, drawing from both Lung transplantation, Lung, Transplantation, Perioperative and Radiation therapy.

Between 2016 and 2021, his most popular works were:

  • Lung cancer screening, version 3.2018 (139 citations)
  • Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline. (66 citations)
  • Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival. (33 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Surgery
  • Cancer

Bryan F. Meyers mainly investigates Lung cancer, Lung transplantation, Surgery, Hazard ratio and Internal medicine. His studies examine the connections between Lung cancer and genetics, as well as such issues in Stage, with regards to Radiology, Stereotactic body radiotherapy, Radiation oncology and Guideline. The Lung transplantation portion of his research involves studies in Lung and Transplantation.

His Lung research integrates issues from COPD and Retrospective cohort study. Bryan F. Meyers mostly deals with Proportional hazards model in his studies of Surgery. His research in Esophagectomy tackles topics such as Oncology which are related to areas like Adenocarcinoma and Propensity score matching.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network

Eric A. Collisson;Joshua D. Campbell;Angela N. Brooks;Angela N. Brooks;Alice H. Berger.
Nature (2014)

3641 Citations

Morbidity and Mortality of Major Pulmonary Resections in Patients With Early-Stage Lung Cancer: Initial Results of the Randomized, Prospective ACOSOG Z0030 Trial

Mark S. Allen;Gail E. Darling;Taine T.V. Pechet;John D. Mitchell.
The Annals of Thoracic Surgery (2006)

766 Citations

The current role of mediastinoscopy in the evaluation of thoracic disease

Zane T. Hammoud;Richard C. Anderson;Bryan F. Meyers;Tracey J. Guthrie.
The Journal of Thoracic and Cardiovascular Surgery (1999)

433 Citations

Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome.

Shiraz A. Daud;Roger D. Yusen;Bryan F. Meyers;Murali M. Chakinala.
American Journal of Respiratory and Critical Care Medicine (2007)

427 Citations

Video-assisted thoracic surgery versus open lobectomy for lung cancer: a secondary analysis of data from the American College of Surgeons Oncology Group Z0030 randomized clinical trial.

Walter J. Scott;Mark S. Allen;Gail Darling;Bryan Meyers.
The Journal of Thoracic and Cardiovascular Surgery (2010)

362 Citations

Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non–small cell lung cancer

Carolyn E Reed;David H Harpole;Katherine E Posther;Sandra L Woolson.
The Journal of Thoracic and Cardiovascular Surgery (2003)

339 Citations

Stereotactic body radiation therapy versus surgical resection for stage I non–small cell lung cancer

Traves D. Crabtree;Chadrick E. Denlinger;Bryan F. Meyers;Issam El Naqa.
The Journal of Thoracic and Cardiovascular Surgery (2010)

259 Citations

Bronchial fenestration improves expiratory flow in emphysematous human lungs.

Henning F Lausberg;Kimiaki Chino;G.Alexander Patterson;Bryan F Meyers.
The Annals of Thoracic Surgery (2003)

250 Citations

Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation

Ramsey R. Hachem;Roger D. Yusen;Bryan F. Meyers;Aviva A. Aloush.
Journal of Heart and Lung Transplantation (2010)

247 Citations

Long-term outcome of bilateral lung volume reduction in 250 consecutive patients with emphysema

Anna Maria Ciccone;Bryan F. Meyers;Tracey J. Guthrie;Gail E. Davis.
The Journal of Thoracic and Cardiovascular Surgery (2003)

240 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Bryan F. Meyers

Thomas A. D'Amico

Thomas A. D'Amico

Duke University

Publications: 78

Shaf Keshavjee

Shaf Keshavjee

University Health Network

Publications: 74

Frank C. Detterbeck

Frank C. Detterbeck

Yale University

Publications: 62

John V. Heymach

John V. Heymach

The University of Texas MD Anderson Cancer Center

Publications: 56

David R. Jones

David R. Jones

Memorial Sloan Kettering Cancer Center

Publications: 53

Ignacio I. Wistuba

Ignacio I. Wistuba

The University of Texas MD Anderson Cancer Center

Publications: 52

Suresh Senan

Suresh Senan

University of Amsterdam

Publications: 46

Nasser K. Altorki

Nasser K. Altorki

NewYork–Presbyterian Hospital

Publications: 45

Jason D. Christie

Jason D. Christie

University of Pennsylvania

Publications: 44

Matthew Meyerson

Matthew Meyerson

Harvard University

Publications: 44

Walter Weder

Walter Weder

University of Zurich

Publications: 43

Valerie W. Rusch

Valerie W. Rusch

Memorial Sloan Kettering Cancer Center

Publications: 43

Scott M. Palmer

Scott M. Palmer

Duke University

Publications: 39

William D. Travis

William D. Travis

Memorial Sloan Kettering Cancer Center

Publications: 39

James D. Luketich

James D. Luketich

University of Pittsburgh

Publications: 35

Ming-Sound Tsao

Ming-Sound Tsao

Princess Margaret Cancer Centre

Publications: 34

Trending Scientists

Maxim Kontsevich

Maxim Kontsevich

Institut des Hautes Études Scientifiques

Xinyuan Wu

Xinyuan Wu

Nanjing University

Frederick E. Petry

Frederick E. Petry

United States Naval Research Laboratory

Yozo Fujino

Yozo Fujino

Yokohama National University

Dean L. Urban

Dean L. Urban

Duke University

Stevan R. Hubbard

Stevan R. Hubbard

New York University

D.J. Buckley

D.J. Buckley

University College Cork

Ali Polat

Ali Polat

University of Windsor

George R. Tilton

George R. Tilton

University of California, Santa Barbara

Markus Kiefer

Markus Kiefer

University of Ulm

Harry L. Malech

Harry L. Malech

National Institutes of Health

David J. Hargreaves

David J. Hargreaves

AstraZeneca (United Kingdom)

Paul Roderick

Paul Roderick

University of Southampton

Stephen M Shalet

Stephen M Shalet

National Health Service

Xiaohu Yang

Xiaohu Yang

University of Science and Technology of China

Alexey Vikhlinin

Alexey Vikhlinin

Harvard University

Something went wrong. Please try again later.